Therapeutic Targets and Therapies for the Treatment of Oral Cancer and Oral Diseases
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 31 January 2025 | Viewed by 89
Special Issue Editor
Interests: oral cancer; oral pathology; oral medicine; dentistry; oncology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Oral cancer and oral diseases are a significant public health concern worldwide, affecting millions of individuals each year. Advances in medical research have led to the development of numerous therapies for the treatment of these conditions, ranging from traditional surgical approaches to cutting-edge targeted and immunological therapies. This Special Issue aims to provide an overview of the current state of therapies for oral cancer and oral diseases.
The treatment of oral cancer and oral diseases has evolved significantly in recent years, with advances in surgical techniques, radiation therapies, chemotherapy, immunotherapy, and other modalities. A multidisciplinary approach, combining different therapies based on the individual patient's needs and tumor characteristics, is often the most effective strategy for achieving optimal outcomes. Further research is needed to develop more targeted and effective therapies for these conditions.
In this Special Issue, we invite front-line researchers and investigators to submit both original research and review articles regarding, but not limited to, the following potential topics focusing on the treatment of oral cancer and oral diseases.
Dr. Maria Eleonora Bizzoca
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- oral cancer
- oral and maxillofacial surgery
- oral and maxillofacial pathology medicine
- periodontics and oral pathology
- immunohistochemistry
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
